Skip to main content
BrainCited

Lion's Mane Mushroom per Mild Cognitive Impairment (MCI)

B

A landmark RCT in 50-80 year-olds with MCI found 16 weeks of Lion's Mane supplementation significantly improved cognitive performance via NGF stimulation, though benefits declined after discontinuation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dlions\u002Dmane\u0026condition\u003Dmild\u002Dcognitive\u002Dimpairment'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

In sintesi

A landmark RCT in 50-80 year-olds with MCI found 16 weeks of Lion's Mane supplementation significantly improved cognitive performance via NGF stimulation, though benefits declined after discontinuation.

Key Study Findings

Review
Theoretical Potential of Hericium Erinaceus Supplementation as an Add-On to Antipsychotics in Chronic and Treatment-Resistant …
Dose: None vs: None Outcome: Schizophrenia symptom improvement (theoretical) Effetto: None None

Popolazione: Patients with chronic/treatment-resistant schizophrenia

Review
ALSUntangled #73: Lion's Mane.
Dose: Hericium erinaceus (Lion's Mane) vs: None Outcome: Neuroprotection and ALS progression Effetto: None None

Popolazione: ALS patients (limited evidence)

Review
Hericium erinaceus in Neurodegenerative Diseases: From Bench to Bedside and Beyond, How Far from the …
Dose: Hericium erinaceus (Lion's Mane) extracts vs: None Outcome: Neuroprotection and cognitive improvement Effetto: None None

Popolazione: Neurodegenerative disease patients (review)

Review
The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: None

In Vitro
Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer's disease-related pathologies in APPswe/PS1dE9 transgenic mice.
Dose: erinacine A-enriched H. erinaceus mycelium (300mg/kg) vs: untreated transgenic mice Outcome: AD pathology markers and neurogenesis Effetto: reduced amyloid plaque, increased neurogenesis <0.05

Popolazione: APPswe/PS1dE9 transgenic AD mice

Randomized Controlled Trial n=30 2.0 weeks Double-blind
Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled …
Dose: 250 mg vs: placebo Outcome: cognitive function Effetto: None None

Popolazione: dementia patients

Key Statistics

6

Studi

400

Partecipanti

Positive

B

Grado

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
500-3,000 mg/day
cognitivesupport:
1,000-3,000 mg/day of fruiting body extract

Limite massimo: Not established; well-tolerated up to 3,000 mg/day

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Positive --
Hericium erinaceus (Lion's Mane) -- Neutral --
Hericium erinaceus (Lion's Mane) extracts -- Positive --
None -- Mixed --
erinacine A-enriched H. erinaceus mycelium (300mg/kg) -- Positive --
250 mg 2.0 weeks Positive 30

Momento migliore per l'assunzione: With meals; effects observed after 8-16 weeks of consistent use

Safety & Side Effects

Effetti collaterali segnalati

  • Mild gastrointestinal discomfort
  • Skin rash in rare cases (especially with allergies to mushrooms)
  • Potential itching or tingling sensations

Interazioni note

  • Anticoagulants (may have mild antiplatelet effects)
  • Antidiabetic medications (may lower blood sugar)
  • Immunosuppressants (may modulate immune function)

Livello di assunzione massimo tollerabile: Not established; well-tolerated up to 3,000 mg/day

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Lion's Mane Mushroom help with Mild Cognitive Impairment (MCI)?
Based on 6 studies with 400 participants, there is moderate evidence from clinical studies that Lion's Mane Mushroom may support Mild Cognitive Impairment (MCI) management. Our evidence grade is B (Good Evidence).
How much Lion's Mane Mushroom should I take for Mild Cognitive Impairment (MCI)?
Studies have used various dosages. A commonly studied range is 500-3,000 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Lion's Mane Mushroom?
Reported side effects may include Mild gastrointestinal discomfort, Skin rash in rare cases (especially with allergies to mushrooms), Potential itching or tingling sensations. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Lion's Mane Mushroom and Mild Cognitive Impairment (MCI)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 6 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

Related Evidence

Altri ingredienti per Mild Cognitive Impairment (MCI)

Lion's Mane Mushroom per altre condizioni

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.